Abstract

Aims To determine the prognosis, cause of death, and its determinants in participants of the population-based Rotterdam Study who were found to have heart failure.

Methods and Results In 5255 Rotterdam Study participants (aged 68·9±8·6 years, 3113 women) the presence of heart failure was determined. Data were analysed with Cox's proportional-hazards models. One hundred and eighty-one participants (age 77·3±7·9 years, 109 women) had heart failure. Of these 85 (47%) died during the 4·8–8·5 (mean 6·1) years of follow-up. One, 2 and 5 years' survival was 89%, 79%, and 59%, representing an age-adjusted mortality twice that of persons without heart failure (hazard ratio 2·1, 95% CI 1·8–2·7). The hazard ratio for sudden death was even more pronounced: 4·8, (95% CI 2·6–8·7). Diabetes mellitus, impairment of renal function and atrial fibrillation were associated with a poor outcome. A higher blood pressure and body mass index conferred a more favourable prognosis in those with heart failure.

Conclusion Heart failure generally afflicts older subjects in the community, carries a poor prognosis, especially in the presence of concomitant diseases, and confers a fivefold increase in the risk of sudden death.

f1
Correspondence: Arend Mosterd, PhD, Department of Cardiology, Eemland Hospital, Utrechtseweg 160, 3818 ES Amersfoort, The Netherlands.

References

1
Bonneux
L
, Barendregt JJ, Meeter K, Bonsel GJ, van der Maas PJ. Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure.
Am J Public Health
 .
1994
;
84
:
20
–28
2
Cowie
MR
, Mosterd A, Wood DA. The epidemiology of heart failure.
Eur Heart J
 .
1997
;
18
:
208
–225
3
Reitsma
JB
, Mosterd A, de Craen AJ. Increase in hospital admission rates for heart failure in The Netherlands, 1980–1993.
Heart
 .
1996
;
76
:
388
–392
4
Cowie
MR
, Wood DA, Coats AJW. Incidence and aetiology of heart failure: a population-based study.
Eur Heart J
 .
1998
;
20
:
421
–428
5
McDonagh
TA
, Morrison CE, Lawrence A. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population.
Lancet
 .
1997
;
350
:
829
–833
6
Mosterd
A
, Hoes AW, Bruijne de MC. Prevalence of heart failure and left ventricular dysfunction in the general population. The Rotterdam Study.
Eur Heart J
 .
1999
;
20
:
447
–455
7
Morgan
S
, Smith H, Simpson I. Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional survey.
BMJ
 .
1999
;
318
:
368
–372
8
Cowie
MR
, Wood DA, Coats AJ. Survival of patients with a new diagnosis of heart failure: a population-based study.
Heart
 .
2000
;
83
:
505
–510
9
Senni
M
, Tribouilloy CM, Rodeheffer RJ. Congestive heart failure in the community: trends in incidence and survival in a 10-year period.
Arch Intern Med
 .
1998
;
159
:
29
–34
10
Hofman
A
, Grobbee DE, de Jong PT, van den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study.
Eur J Epidemiol
 .
1991
;
7
:
403
–422
11
Rose
GA
, McCartney P, Reid DD. Self-administration of a questionnaire on chest pain and intermittent claudication.
Br J Prev Soc Med
 .
1977
;
31
:
42
–53
12
Rose, GA, Blackburn, H, Cardiovascular survey methods, Geneva, WHO, 1968
13
Anatomical Therapeutical Chemical (ATC) classification index, Oslo, Norway, WHO Collaborating Centre for Drug Statistics Methodology, 1992
14
Cockcroft
DW
, Gault MH. Prediction of creatinine clearance from serum creatinine.
Nephron
 .
1976
;
16
:
31
–41
15
Willems
JL
, Abreu-Lima C, Arnaud P. The diagnostic performance of computer programs for the interpretation of electrocardiograms.
N Engl J Med
 .
1991
;
325
:
1767
–1773
16
De Bruyne
MC
, Hoes AW, Kors JA, Hofman A, van Bemmel JH, Grobbee DE. QTc dispersion predicts cardiac mortality in the elderly: the Rotterdam Study.
Circulation
 .
1998
;
97
:
467
–472
17
Kors
JA
, De Bruyne MC, Hoes AW. T axis as an indicator of risk of cardiac events in elderly people.
Lancet
 .
1998
;
352
:
601
–605
18
Quinones
MA
, Pickering E, Alexander JK. Percentage of shortening of the echocardiographic left ventricular dimension. Its use in determining ejection fraction and stroke volume.
Chest
 .
1978
;
74
:
59
–65
19
Mosterd
A
, Deckers JW, Hoes AW. Classification of heart failure in population based research: an assessment of six heart failure scores.
Eur J Epidemiol
 .
1997
;
13
:
491
–502
20
International statistical classification of diseases and related health problems, 10th revision, Geneva, WHO, 1992
21
Cupples
LA
, Cagnon DR, Kannel WB. Long- and short-term risk of sudden coronary death.
Circulation
 .
1992
;
85
:
11
–18
22
Cleland
JG
, Erhardt L, Hall AS, Winter C, Ball SG. Validation of primary and secondary outcomes and classification of mode of death among patients with clinical evidence of heart failure after a myocardial infarction: a report from the Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.
J Cardiovasc Pharmacol
 .
1993
;
22
:
S22
–27
23
Eur Heart J
 .
1995
;
16
:
741
–751
24
Madsen
BK
, Hansen JF, Stokholm KH, Brons J, Husum D, Mortensen LS. Chronic congestive heart failure. Description and survival of 190 consecutive patients with a diagnosis of chronic congestive heart failure based on clinical signs and symptoms.
Eur Heart J
 .
1994
;
15
:
303
–310
25
Croft
JB
, Giles WH, Pollard RA, Keenan NL, Casper ML, Anda RF. Heart failure survival among older adults in the United States: a poor prognosis for an emerging epidemic in the Medicare population.
Arch Intern Med
 .
1999
;
159
:
505
–510
26
N Engl J Med
 .
1992
;
327
:
685
–691
27
Pfeffer
MA
, Braunwald E, Moye LA. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.
N Engl J Med
 .
1992
;
327
:
669
–677
28
N Engl J Med
 .
1991
;
325
:
293
–302
29
Cohn
JN
, Johnson G, Ziesche S. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.
N Engl J Med
 .
1991
;
325
:
303
–310
30
Eriksson
H
, Wilhelmsen L, Caidahl K, Svardsudd K. Epidemiology and prognosis of heart failure.
Z Kardiol
 .
1991
;
80
:
1
–6
31
Schocken
DD
, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States.
J Am Coll Cardiol
 .
1992
;
20
:
301
–306
32
Kupari
M
, Lindroos M, Iivanainen AM, Heikkila J, Tilvis R. Congestive heart failure in old age: prevalence, mechanisms and 4-year prognosis in the Helsinki Ageing Study.
J Intern Med
 .
1997
;
241
:
387
–394
33
Ho
KK
, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects.
Circulation
 .
1993
;
88
:
107
–115
34
Senni
M
, Tribouilloy CM, Rodeheffer RJ. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991.
Circulation
 .
1998
;
98
:
2282
–2289
35
Kannel
WB
, Plehn JF, Cupples LA. Cardiac failure and sudden death in the Framingham Study.
Am Heart J
 .
1988
;
115
:
869
–875
36
Barr
CS
, Naas A, Freeman M, Lang CC, Struthers AD. QT dispersion and sudden unexpected death in chronic heart failure.
Lancet
 .
1994
;
343
:
327
–329
37
Cohn
JN
. Prognostic factors in heart failure: poverty amidst a wealth of variables.
J Am Coll Cardiol
 .
1989
;
14
:
571
–572
38
Cowburn
PJ
, Cleland JG, Coats AJ, Komajda M. Risk stratification in chronic heart failure.
Eur Heart J
 .
1998
;
19
:
696
–710
39
Dries
DL
, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction.
J Am Coll Cardiol
 .
1998
;
32
:
695
–703
40
Vasan
RS
, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort.
J Am Coll Cardiol
 .
1999
;
33
:
1948
–1955
41
Brown
AM
, Cleland JG. Influence of concomitant disease on patterns of hospitalization in patients with heart failure discharged from Scottish hospitals in 1995.
Eur Heart J
 .
1998
;
19
:
1063
–1069
42
Dries
DL
, Exner DV, Domanski MJ, Greenberg B, Stevenson LW. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction.
J Am Coll Cardiol
 .
2000
;
35
:
681
–689
43
Malmberg
K
. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group.
BMJ
 .
1997
;
314
:
1512
–1515
44
Grossman
E
, Messerli FH. Diabetic and hypertensive heart disease.
Ann Intern Med
 .
1996
;
125
:
304
–310
45
Anker
SD
, Ponikowski P, Varney S. Wasting as independent risk factor for mortality in chronic heart failure.
Lancet
 .
1997
;
349
:
1050
–1053
46
Massie
BM
. 15 years of heart-failure trials: what have we learned?
Lancet
 .
1998
;
352
:
SI29
–33
47
Erhardt
LR
, Cline CM. Organisation of the care of patients with heart failure.
Lancet
 .
1998
;
352
:
SI15
–8

Comments

0 Comments